Are Analysts Bearish Kindred Healthcare, Inc. (NYSE:KND) After Last Week?

June 17, 2018 - By Vivian Park

Kindred Healthcare, Inc. (NYSE:KND) LogoInvestors sentiment increased to 1.03 in Q1 2018. Its up 0.06, from 0.97 in 2017Q4. It improved, as 22 investors sold Kindred Healthcare, Inc. shares while 44 reduced holdings. 22 funds opened positions while 46 raised stakes. 73.05 million shares or 6.66% less from 78.27 million shares in 2017Q4 were reported.
Ls Invest Lc reported 0% of its portfolio in Kindred Healthcare, Inc. (NYSE:KND). Vanguard Gp Inc reported 8.63 million shares or 0% of all its holdings. Goldman Sachs Group stated it has 0% in Kindred Healthcare, Inc. (NYSE:KND). 326,283 were reported by Barclays Pcl. Comerica Financial Bank holds 0.01% of its portfolio in Kindred Healthcare, Inc. (NYSE:KND) for 95,876 shares. Los Angeles & Equity Rech Inc has invested 0.01% in Kindred Healthcare, Inc. (NYSE:KND). Alliancebernstein Ltd Partnership holds 0% of its portfolio in Kindred Healthcare, Inc. (NYSE:KND) for 119,097 shares. Aperio Gru Limited Co holds 0% or 22,176 shares. Parallax Volatility Advisers Limited Partnership holds 0% of its portfolio in Kindred Healthcare, Inc. (NYSE:KND) for 17,751 shares. Raymond James & Associates has 0% invested in Kindred Healthcare, Inc. (NYSE:KND) for 25,150 shares. Schwab Charles Mngmt reported 1.40 million shares. Texas-based Ser Automobile Association has invested 0% in Kindred Healthcare, Inc. (NYSE:KND). Lombard Odier Asset (Usa) has 66,960 shares. 51,776 are owned by Stifel. California State Teachers Retirement holds 0% or 129,509 shares in its portfolio.

Kindred Healthcare, Inc. (NYSE:KND) Ratings Coverage

Among 2 analysts covering Kindred Healthcare (NYSE:KND), 0 have Buy rating, 0 Sell and 2 Hold. Therefore 0 are positive. Kindred Healthcare had 2 analyst reports since December 18, 2017 according to SRatingsIntel. The firm earned “Hold” rating on Tuesday, December 19 by RBC Capital Markets. The stock of Kindred Healthcare, Inc. (NYSE:KND) earned “Hold” rating by Mizuho on Monday, December 18. Below is a list of Kindred Healthcare, Inc. (NYSE:KND) latest ratings and price target changes.

19/12/2017 Broker: RBC Capital Markets Rating: Hold New Target: $9.0 Maintain
18/12/2017 Broker: Mizuho Rating: Hold New Target: $9.0 Maintain

It closed at $9 lastly. It is down 12.25% since June 17, 2017 and is downtrending. It has underperformed by 24.82% the S&P500.

Kindred Healthcare, Inc. provides healthcare services in the United States. The company has market cap of $821.35 million. It operates in six divisions: Hospitals, Home Health Services, Hospice Services, Kindred Hospital Rehabilitation Services, RehabCare, and Nursing Centers. It currently has negative earnings. The firm provides long-term acute care services to post-intensive care and medically complex patients, including the critically ill, suffering from multiple organ system failures, most commonly of the cardiovascular, pulmonary, kidney, gastro-intestinal, and cutaneous systems.

Another recent and important Kindred Healthcare, Inc. (NYSE:KND) news was published by Seekingalpha.com which published an article titled: “Tracking Larry Robbins’ Glenview Capital Management Portfolio – Q1 2018 Update” on May 25, 2018.

Kindred Healthcare, Inc. (NYSE:KND) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: